BTIG research firm reiterated its Buy rating and $21.00 price target for INmune Bio Inc. (NASDAQ:INMB), currently trading at ...

BTIG analysts began covering Arcturus Therapeutics (NASDAQ:ARCT) with a positive outlook, assigning a Buy rating and establishing a price target of $41.00. Currently trading at $16.49 with a market ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be attending the ...

BTIG initiated coverage of Arcturus Therapeutics (ARCT) with a Buy rating and $41 price target Arcturus is a commercial-stage biotechnology ...

Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...

What damage might Monday's ongoing selloff do to the technical set-up for stocks? Well, in a note published on Sunday, BTIG chartist guru Jonathan Krinsky observed that Friday's action had already sug ...

Upwork Inc (UPWK) stock saw a modest uptick, ending the day at $16.82 which represents a slight increase of $0.56 or 3.44% from the prior close of $16.26. The stock opened at $15.98 and touched a low ...

NEW YORK, January 17, 2025--(BUSINESS WIRE)--BTIG announced today that it will commit to donating $1 million dollars to wildfire relief and restoration efforts in Los Angeles, California.

BTIG lowered the firm’s price target on Evolent Health (EVH) to $20 from $29 but keeps a Buy rating on the shares. The firm notes it was disappointed by the company’s comments around higher ...

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, toda ...

(Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the 12 th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference ...